跳至主要内容
临床试验/NCT03832699
NCT03832699Unknown不适用

Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer: a Non-inferiority Randomized Clinical Trial

Wolfson Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Live birth rate

研究概览

简要总结

The current trial is intended to assess the efficacy of oral versus vaginal progesterone for luteal support in frozen IVF cycles.

详细描述

Progesteron is used for luteal phase support in IVF cycles. Progesterone can be administered vaginally and orally. Duphaston is an oral progesterone drug, which has recentlly been proven effective in fresh cycle IVF. Yet, less is known regarding its efficacy in frozen cycle IVF. Thus, the objective of our trial is to compare the efficacy of vaginal and oral progesterone in frozen IVF cycles.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Ages 18-39
  • Modified natural cycle (induction of ovulation with HCG)
  • Consent to participation

排除标准

  • 未提供

研究组 & 干预措施

Oral progesterone

Experimental

干预措施: Dydrogesterone 10 MG (Drug)

Vaginal progesterone

Active Comparator

干预措施: Endometrin 100Mg Vaginal Insert (Drug)

结局指标

主要结局

Live birth rate

时间窗: Up to 9 months

Birth of a live infant after 24 weeks gestation

次要结局

  • Clinical pregnancy rate(Outcome assesed 6-7 weeks following treatment)
  • Implantation rate(Outcome assessed 6-7 weeks following treatment)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hadas Ganer Herman

Principal investigator

Wolfson Medical Center

研究点 (1)

Loading locations...

相似试验

Oral Dydrogesterone vs. Vaginal Micronized... | 临床试验